Printer-friendly version
Send to friendLeadership Council
The LSI Leadership Council is a group of biomedical industry leaders, venture capitalists, and government officials. The council advises and supports the LSI leadership and faculty.
Members
- Rajesh Alva - Managing Director, Head of Healthcare M & A, Credit Suisse
- Mary Campbell - Managing Director, EDF Ventures
- James Flynn - Partner, Deerfield Management Company
- Michael Finney - President and CEO, Michigan Economic Development Corporation
- James Hackett - President and CEO, Steelcase, Inc.
- David Kroin - Managing Director, Great Point Partners, LLC
- Shiraz Ladiwala - VP/GM Asia Pacific, Biosciences, ThermoFisher Scientific
- Julius Li - CEO, AutekBio Inc.
- Ernie Ludy - Founder; Former Chairman and CEO, The Medstat Group
- Greg Margolies - Senior Partner and Head of Capital Markets Group, Ares Management LLC
- Joel Martin - President and CEO, Altair Therapeutics
- Paul Meister - CEO and co-founder, Liberty Lane Partners
- Garry Neil - Corporate VP, Corporate Office of Science & Technology, Johnson & Johnson
- Roger Newton - President and CEO, Esperion Therapeutics
- John Osborn - Executive Vice President, General Counsel, and Corporate Secretary, Dendreon Corporation
- Craig Parker (Chair) - Vice President of Strategy & Corporate Development, Human Genome Sciences, Inc.
- Liam Ratcliffe - Partner, New Leaf Venture Partners, LLC
- Joseph Schwarz - Former US Representative, 7th Congressional District, State of MI
- Greg Simon - Senior VP, Worldwide Policy, Pfizer, Inc.
- Michael Staebler - Partner, Pepper Hamilton, LLP
- David Walt - Robinson Professor of Chemistry, Tufts University, Founder and Director of Illumina, Inc. and Quanterix Corp.
- Wendell Wierenga - Executive Vice President of Research & Development, Santarus, Inc.
- Robert Zerbe - Chief Executive Officer and President, QuatRx
